These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10792385)

  • 1. The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.
    Fijen CA; Bredius RG; Kuijper EJ; Out TA; De Haas M; De Wit AP; Daha MR; De Winkel JG
    Clin Exp Immunol; 2000 May; 120(2):338-45. PubMed ID: 10792385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals.
    Platonov AE; Kuijper EJ; Vershinina IV; Shipulin GA; Westerdaal N; Fijen CA; van de Winkel JG
    Clin Exp Immunol; 1998 Jan; 111(1):97-101. PubMed ID: 9472667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
    Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement in anti-bacterial defence.
    D'Amelio R; Biselli R
    Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease.
    van der Pol WL; Huizinga TW; Vidarsson G; van der Linden MW; Jansen MD; Keijsers V; de Straat FG; Westerdaal NA; de Winkel JG; Westendorp RG
    J Infect Dis; 2001 Dec; 184(12):1548-55. PubMed ID: 11740730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals.
    Ross SC; Rosenthal PJ; Berberich HM; Densen P
    J Infect Dis; 1987 Jun; 155(6):1266-75. PubMed ID: 3106511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in Western Norway.
    Smith I; Vedeler C; Halstensen A
    Epidemiol Infect; 2003 Apr; 130(2):193-9. PubMed ID: 12729187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.
    Bredius RG; Fijen CA; De Haas M; Kuijper EJ; Weening RS; Van de Winkel JG; Out TA
    Immunology; 1994 Dec; 83(4):624-30. PubMed ID: 7875742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease.
    Domingo P; Muñiz-Diaz E; Baraldès MA; Arilla M; Barquet N; Pericas R; Juárez C; Madoz P; Vázquez G
    Am J Med; 2002 Jan; 112(1):19-25. PubMed ID: 11812402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The bactericidal action of human neutrophils on meningococci in vitro].
    Platonov AE; Vershinina IV; Käyhty H; Fijen CA; Kuijper EJ
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):46-52. PubMed ID: 10851990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.
    Sanders LA; Feldman RG; Voorhorst-Ogink MM; de Haas M; Rijkers GT; Capel PJ; Zegers BJ; van de Winkel JG
    Infect Immun; 1995 Jan; 63(1):73-81. PubMed ID: 7806386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients.
    Platonov AE; Vershinina IV; Käyhty H; Fijen CA; Würzner R; Kuijper EJ
    Int Arch Allergy Immunol; 2003 Apr; 130(4):314-21. PubMed ID: 12740533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands.
    Fijen CA; Kuijper EJ; te Bulte MT; Daha MR; Dankert J
    Clin Infect Dis; 1999 Jan; 28(1):98-105. PubMed ID: 10028078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease.
    Platonov AE; Shipulin GA; Vershinina IV; Dankert J; van de Winkel JG; Kuijper EJ
    Clin Infect Dis; 1998 Oct; 27(4):746-50. PubMed ID: 9798027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of FcγRIIIb polymorphism on its ability to cooperate with FcγRIIa and CR3 in mediating the oxidative burst of human neutrophils.
    Urbaczek AC; Toller-Kawahisa JE; Fonseca LM; Costa PI; Faria CM; Azzolini AE; Lucisano-Valim YM; Marzocchi-Machado CM
    Hum Immunol; 2014 Aug; 75(8):785-90. PubMed ID: 24945596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal capacity against Neisseria meningitidis of normal human serum and sera with functional deficiencies of the third and eight complement factor.
    Strate M; Olsen H; Teisner B
    Eur J Clin Invest; 1987 Jun; 17(3):226-30. PubMed ID: 3113967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fcgamma receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera.
    Jansen WT; Breukels MA; Snippe H; Sanders LA; Verheul AF; Rijkers GT
    J Infect Dis; 1999 Sep; 180(3):888-91. PubMed ID: 10438387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups.
    Fijen CA; Kuijper EJ; Hannema AJ; Sjöholm AG; van Putten JP
    Lancet; 1989 Sep; 2(8663):585-8. PubMed ID: 2570284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.
    Söderström C; Braconier JH; Käyhty H; Sjöholm AG; Thuresson B
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):220-4. PubMed ID: 2496990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA.
    van Schie RC; Wilson ME
    Clin Diagn Lab Immunol; 2000 Jul; 7(4):676-81. PubMed ID: 10882671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.